APRE (Aprea Therapeutics) Preferred Dividends: $0.00 Mil (TTM As of Mar. 2026)

What is Aprea Therapeutics Preferred Dividends?

Aprea Therapeutics APRE +2.34% 30 Preferred Dividends is $0.00 Mil as of Mar. 2026. GuruFocus rates APRE with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Aprea Therapeutics's preferred dividends for the three months ended in Mar. 2026 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Aprea Therapeutics (NAS:APRE) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprea Therapeutics Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Aprea Therapeutics's Preferred Dividends can be seen below:

Aprea Therapeutics Preferred Dividends Chart

Aprea Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Preferred Dividends

Get a 7-Day Free Trial

0.00

Aprea Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Preferred Dividends	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

30GF Score

Aprea Therapeutics Inc APRE

Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aprea Therapeutics Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →

What does a Preferred Dividends of $0.00 Mil mean?

Aprea Therapeutics (APRE) has a Preferred Dividends of $0.00 Mil as of Mar. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Aprea Therapeutics and its competitors.

Is Aprea Therapeutics' Preferred Dividends too high?

Aprea Therapeutics' current Preferred Dividends is $0.00 Mil. Overall, Aprea Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Aprea Therapeutics' Preferred Dividends compare to JSPR and CVKD?

Aprea Therapeutics' Preferred Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Preferred Dividends for a Biotechnology company?

A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Preferred Dividends mean?

A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Aprea Therapeutics and its competitors. Aprea Therapeutics's current Preferred Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aprea Therapeutics stock overvalued right now?

Aprea Therapeutics (APRE) has a current Preferred Dividends of $0.00 Mil. The current Preferred Dividends is $0.00 Mil. Aprea Therapeutics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Preferred Dividends calculated?

Preferred Dividends is calculated from a company's financial statements. For Aprea Therapeutics (APRE), the current Preferred Dividends is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprea Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies JSPR CVKD BRTX BCLI ADAPY RVPH AIM INTS BOLT KPRX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 3805 Old Easton Road, Doylestown, PA, USA, 18902

Website https://www.aprea.com

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

30GF Score

Get the complete analysis for APRE

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75

Price

View APRE Analysis

See Preferred Dividends data for all stocks →